Nexentis Technologies Inc. (NXTS)
Nasdaq: NXTS · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2019
Who owns Nexentis Technologies Inc.
As filed with the SECHolders of 5% or more
4
SciSparc Ltd. holds 18.3% of Common Stock, $0.0001 par value per share, as its SCHEDULE 13G filed Oct 24, 2025 says.
Directors and officers
9
report now, of 20 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
SciSparc Ltd.
SCHEDULE 13G · filed Oct 24, 2025 · Common Stock, $0.0001 par value per share
Alon Silberman
SCHEDULE 13G · filed Oct 28, 2025 · Common Stock, $0.0001 par value per share
Kfir Silberman
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.0001 par value per share · 9.99% in Feb 24, 2025
Amir Uziel
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.0001 par value per share · 9.99% in Feb 24, 2025
Ciro Leonardo Pierri.
SCHEDULE 13G/A · filed Feb 24, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 5.03% in Feb 12, 2026
Capitalink Ltd.
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 8.82% in Feb 24, 2025
Lee Eun Young
SCHEDULE 13G/A · filed Jul 15, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 9.38% in Mar 23, 2026
What NXTS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
MitoCareX Bio Ltd
A company bought · acquisition · Oct 2025 · owns, named in the 10-K filed Mar 31, 2026
Mito Care X
A company bought · acquisition · owns, named in the 10-K filed Mar 31, 2026
3 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 31, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 22, 2025 to Oct 22, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Oct 22, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 25 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Lee Eun Young | 10% owner | 1 | $0 | 0 | 0 | $0 |